CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/22/2022
Back to search
Official data from USPTO
AGERA RX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
09/22/2022
Trademark type
Word
Nice classes
3, 5
Filing date
03/13/2007
Registration date
04/22/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/20/2017
Last transaction
09/22/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/01/2001
First use in commerce
04/01/2001
Drawing code
4
Owner type
03
Owner location
Horsham, PA, US
Examiner
SPARROW,MARY
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Agera Laboratories, Inc.
Agera Laboratories, Inc.
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
non-medicated skin care preparationsserumslotionscreamsgelsmasks and sprays; cosmetic productsskin cleanersskin exfoliatesskin lotions and skin moisturizers
Class 5
cosmetic productsvitamin supplements designed to promote youthful looking skin; pharmaceutical or medical preparations containing fibroblast cells for injecting under the skin for wrinkle reductionreduction of acne conditions or reduction of scars of the skin or for injecting or surgically implanting into the gums or around the teeth; synthetic peptides for pharmaceutical purposes; amino acid sequences for medical or veterinary purposes; pharmaceutical products for the treatment of dermatologic conditionswound healingcancerscardiovascular diseasesviral and infectious diseasesdiseases of the immune systemgenetic disordersophthalmic diseases
Publications
History of USPTO decisions and trademark events.
37 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/22/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/22/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/20/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/20/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/20/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
11/13/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/22/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/28/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/28/2013
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/28/2013
PAPER RECEIVED
04/23/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
04/22/2013
E815
TEAS SECTION 8 & 15 RECEIVED
04/22/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
04/22/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/19/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/19/2008
DOCK
ASSIGNED TO EXAMINER
03/11/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/27/2008
IUAF
USE AMENDMENT FILED
02/05/2008
EISU
TEAS STATEMENT OF USE RECEIVED
02/05/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/08/2008
PUBO
PUBLISHED FOR OPPOSITION
10/16/2007
NPUB
NOTICE OF PUBLICATION
09/26/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/12/2007
ALIE
ASSIGNED TO LIE
09/12/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/02/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2007
GNRT
NON-FINAL ACTION E-MAILED
06/23/2007
CNRT
NON-FINAL ACTION WRITTEN
06/23/2007
DOCK
ASSIGNED TO EXAMINER
06/23/2007
NWAP
NEW APPLICATION ENTERED
03/16/2007
Continuous trademark protection
Get notified about every new filing that threatens AGERA RX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.